Libbs Farmaceutica Ltda:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Libbs Farmaceutica Ltda - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0465
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Libbs Farmaceutica Ltda (Libbs Farmaceutica) is a pharmaceutical company which manufactures and supply medications for human healthcare. The company offers monoclonal antibodies in various specialties which include cardiovascular, gynecology, oncology, dermatology, respiratory, and central nervous system transplant. It also produces active pharmaceutical ingredients, drugs and other medical products. Libbs Farmaceutica provides products in several dosage forms including injectable solutions, drops, tablets, capsules, coated tablets, powders, moisturizing fluids, gels and creams. The company carries its synthesis of active ingredients and manufacturing of medicines at its units located in Barra Funda and Embu das Artes, Sao Paulo. Libbs Farmaceutica is headquartered in Sao Paulo, Brazil.

Libbs Farmaceutica Ltda – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cristalia, Biolab, Eurofarma And Libbs Enter Into Joint Venture For Biological Medicines 10
Licensing Agreements 11
Libbs Farmaceutica to Enter into Licensing Agreement with Mithra Pharmaceuticals 11
BHV Pharma Enters into Licensing Agreement with Libbs Farmaceutica for Remogliflozin Etabonate 12
Libbs Farma Enters Into Licensing Agreement With mAbxience For Biosimilar Monoclonal Antibodies 13
Libbs Farmaceutica Ltda – Key Competitors 14
Libbs Farmaceutica Ltda – Key Employees 15
Libbs Farmaceutica Ltda – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Key Facts 2
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Libbs Farmaceutica Ltda, Deals By Therapy Area, 2012 to YTD 2018 8
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cristalia, Biolab, Eurofarma And Libbs Enter Into Joint Venture For Biological Medicines 10
Libbs Farmaceutica to Enter into Licensing Agreement with Mithra Pharmaceuticals 11
BHV Pharma Enters into Licensing Agreement with Libbs Farmaceutica for Remogliflozin Etabonate 12
Libbs Farma Enters Into Licensing Agreement With mAbxience For Biosimilar Monoclonal Antibodies 13
Libbs Farmaceutica Ltda, Key Competitors 14
Libbs Farmaceutica Ltda, Key Employees 15
Libbs Farmaceutica Ltda, Other Locations 16

List of Figures
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Libbs Farmaceutica Ltda, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Libbs Farmaceutica Ltda:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 21st Century Oncology Inc:企業の戦略的SWOT分析
    21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Novo Nordisk AS (NOVO B)-製薬・医療分野:企業M&A・提携分析
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Alten SA:企業の戦略・SWOT・財務情報
    Alten SA - Strategy, SWOT and Corporate Finance Report Summary Alten SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • PT Supreme Cable Manufacturing & Commerce Tbk (SCCO):企業の財務・戦略的SWOT分析
    PT Supreme Cable Manufacturing & Commerce Tbk (SCCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Huntsman Corp (HUN):企業の財務・戦略的SWOT分析
    Huntsman Corp (HUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Lixil Group Corporation (5938):企業の財務・戦略的SWOT分析
    Lixil Group Corporation (5938) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Euronet Worldwide Inc (EEFT):企業の財務・戦略的SWOT分析
    Euronet Worldwide Inc (EEFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PT Bank Central Asia Tbk:企業の戦略・SWOT・財務情報
    PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Central Asia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Divi’s Laboratories Ltd (DIVISLAB):企業の財務・戦略的SWOT分析
    Divi's Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Gujarat Power Corporation Ltd:電力:M&Aディール及び事業提携情報
    Summary Gujarat Power Corporation Ltd (GPCL) is a power corporation that produces and supplies renewable energy for the state of Gujarat. The corporation is also named as Nodal Agency by the Government of Gujarat for development of Solar Park. It generates solar energy from solar energy generation p …
  • aap Implantate AG (AAQ):企業の財務・戦略的SWOT分析
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • Telekom Malaysia Berhad (TM):企業の財務・戦略的SWOT分析
    Telekom Malaysia Berhad (TM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hoerbiger Holding AG:企業の戦略的SWOT分析
    Hoerbiger Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • CMA CGM SA:企業の戦略・SWOT・財務情報
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Probiogen AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Probiogen AG (Probiogen) a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeut …
  • The Medicines Company (MDCO):製薬・医療:M&Aディール及び事業提携情報
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products a peptide compound that inhibits an intravenous direct thrombin and needle …
  • Dechra Pharmaceuticals Plc (DPH):企業の財務・戦略的SWOT分析
    Summary Dechra Pharmaceuticals Plc (Dechra) is a manufacturer and distributor of veterinary pharmaceutical products. The company's product portfolio includes vetoryl, felimazole, thyforon, malaseb, canaural, isaderm, cardisure, comfortan, libromide, somulose, vetoryl, rapidexon, octacillin, domidine …
  • Volt Information Sciences Inc (VOLT):企業の財務・戦略的SWOT分析
    Volt Information Sciences Inc (VOLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Amarin Corp Plc (AMRN):製薬・医療:M&Aディール及び事業提携情報
    Summary Amarin Corp Plc (Amarin) is a biopharmaceutical company which develops and commercializes medicines for cardiovascular domain. The company's lead product Vascepa (icosapent ethyl) is a US FDA approved single-molecule prescription capsule used as an adjunct to diet, for the reduction of trigl …
  • Lario Oil & Gas Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Lario Oil & Gas Company (Lario Oil & Gas) is an oil and gas exploration and production company that explores and produces oil and gas properties. The company offers services such as discovering reserves organically from geologic thesis, drill-bit, field delineation, and land acquisition and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆